PlainRecalls
FDA Drug Low Class III Terminated

Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038

Reported: March 21, 2018 Initiated: March 5, 2018 #D-0599-2018

Product Description

Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
Novel Laboratories, Inc.
Units Affected
134,364 bottles (4,030,920 tablets)
Distribution
Nationwide
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038. Recalled by Novel Laboratories, Inc.. Units affected: 134,364 bottles (4,030,920 tablets).
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 21, 2018. Severity: Low. Recall number: D-0599-2018.